Free Trial

William Blair Has Bullish Outlook for CWK FY2025 Earnings

Cushman & Wakefield logo with Finance background

Key Points

  • William Blair has raised its FY2025 EPS estimate for Cushman & Wakefield from $1.14 to $1.20, aligning with the consensus estimate for the year.
  • Cushman & Wakefield reported a quarterly EPS of $0.30, exceeding the consensus estimate of $0.22, despite revenue falling short of expectations at $1.65 billion.
  • Analysts have mixed opinions on the stock, with ratings ranging from "strong buy" to "sell," and a consensus price target of $13.63.
  • Want stock alerts on Cushman & Wakefield? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Cushman & Wakefield PLC (NYSE:CWK - Free Report) - Investment analysts at William Blair boosted their FY2025 earnings per share (EPS) estimates for Cushman & Wakefield in a research report issued to clients and investors on Tuesday, August 5th. William Blair analyst S. Sheldon now anticipates that the company will post earnings per share of $1.20 for the year, up from their prior estimate of $1.14. The consensus estimate for Cushman & Wakefield's current full-year earnings is $1.20 per share. William Blair also issued estimates for Cushman & Wakefield's Q4 2025 earnings at $0.57 EPS, Q1 2026 earnings at $0.13 EPS, Q2 2026 earnings at $0.39 EPS, Q4 2026 earnings at $0.68 EPS, FY2026 earnings at $1.53 EPS and FY2027 earnings at $1.82 EPS.

Cushman & Wakefield (NYSE:CWK - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.08. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $2.38 billion. Cushman & Wakefield had a return on equity of 14.33% and a net margin of 2.11%. The business's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $0.20 EPS.

Several other equities analysts have also recently weighed in on the company. JPMorgan Chase & Co. cut their price objective on Cushman & Wakefield from $17.00 to $14.00 and set a "neutral" rating for the company in a research report on Thursday, April 10th. JMP Securities upped their target price on shares of Cushman & Wakefield from $15.00 to $16.00 and gave the stock a "market outperform" rating in a research note on Wednesday. Morgan Stanley set a $14.50 price target on Cushman & Wakefield and gave the stock an "overweight" rating in a report on Thursday, June 12th. Wall Street Zen downgraded shares of Cushman & Wakefield from a "strong-buy" rating to a "buy" rating in a research note on Sunday, July 20th. Finally, Citizens Jmp began coverage on Cushman & Wakefield in a research report on Monday, July 21st. They set a "strong-buy" rating and a $15.00 price objective for the company. One analyst has rated the stock with a sell rating, four have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $13.63.

Read Our Latest Stock Analysis on Cushman & Wakefield

Cushman & Wakefield Stock Up 2.2%

Shares of NYSE:CWK opened at $13.69 on Thursday. The company has a market cap of $3.17 billion, a PE ratio of 15.56 and a beta of 1.50. Cushman & Wakefield has a 52 week low of $7.64 and a 52 week high of $16.11. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.18 and a current ratio of 1.13. The firm has a 50 day simple moving average of $11.23 and a 200 day simple moving average of $10.97.

Institutional Trading of Cushman & Wakefield

Large investors have recently bought and sold shares of the business. Yousif Capital Management LLC boosted its position in Cushman & Wakefield by 1.0% in the 2nd quarter. Yousif Capital Management LLC now owns 90,691 shares of the company's stock valued at $1,004,000 after buying an additional 934 shares during the period. Oliver Luxxe Assets LLC increased its position in Cushman & Wakefield by 1.0% in the 2nd quarter. Oliver Luxxe Assets LLC now owns 116,909 shares of the company's stock valued at $1,294,000 after acquiring an additional 1,118 shares during the period. Knights of Columbus Asset Advisors LLC increased its stake in shares of Cushman & Wakefield by 2.7% during the first quarter. Knights of Columbus Asset Advisors LLC now owns 78,751 shares of the company's stock worth $805,000 after acquiring an additional 2,070 shares during the period. Vident Advisory LLC lifted its position in shares of Cushman & Wakefield by 18.1% during the 1st quarter. Vident Advisory LLC now owns 17,310 shares of the company's stock valued at $177,000 after acquiring an additional 2,656 shares during the period. Finally, Bank of Montreal Can increased its holdings in Cushman & Wakefield by 4.9% during the 2nd quarter. Bank of Montreal Can now owns 61,130 shares of the company's stock valued at $677,000 after acquiring an additional 2,876 shares in the last quarter. Hedge funds and other institutional investors own 95.56% of the company's stock.

Cushman & Wakefield Company Profile

(Get Free Report)

Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.

See Also

Earnings History and Estimates for Cushman & Wakefield (NYSE:CWK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cushman & Wakefield Right Now?

Before you consider Cushman & Wakefield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman & Wakefield wasn't on the list.

While Cushman & Wakefield currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines